Historically viewed as recession-proof, 2023 is expected to be a challenging year for the healthcare industry as macroeconomic factors – inflation, high labor expenses, volatile markets, supply chain snarls and other issues – exert their influence in ways not previously seen, according to McDermott Will & Emery’s Healthcare practice. In addition, healthcare providers – including hospitals and health systems – must grapple with the end of the COVID-19 public health emergency (PHE), which will require unwinding the multi-layered changes that were put into effect during the PHE. Read more.
Related Posts
Home-Based Care M&A Volume Mostly Flat At End of 2022
In total, 2022 saw a little more than 100 transactions, which is in line with pre-pandemic levels.
March 1, 2023
Providers’ Best Weapon Against the ‘Retail Revolution’? Digital Health Transformation
An expert offers perspective on what hospitals and health systems should be doing to hold their own against competitors such as Amazon, CVS, Walgreens and Walmart.
May 17, 2022
Exclusive: CFO Strategy in 2023
According to the 2023 BDO Healthcare CFO Outlook Survey, another major M&A driver this year is expanding into a new market segment, a trend driven mostly by outpatient facilities and ASCs, with 40% citing it as their top goal.
January 30, 2023
PE Owners of Nursing Homes Face Disclosure Demand in U.S. Bill
The Healthcare Ownership Transparency Act, which failed to move out of committee when introduced last year, would compel firms to list investors, debt, fees collected, and performance details.
March 24, 2023